John Dobak - Mar 7, 2022 Form 4 Insider Report for DermTech, Inc. (DMTK)

Role
Chief Executive Officer, Director
Signature
/s/ Jason S. Miller, attorney-in-fact
Stock symbol
DMTK
Transactions as of
Mar 7, 2022
Transactions value $
-$43,305
Form type
4
Date filed
3/9/2022, 07:04 PM
Previous filing
Dec 16, 2021
Next filing
Mar 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DMTK Common Stock Sale -$33.4K -2.56K -0.57% $13.03* 449K Mar 7, 2022 Direct F1, F2
transaction DMTK Common Stock Sale -$9.94K -786 -0.18% $12.64* 448K Mar 8, 2022 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on March 29, 2021.
F2 Includes 660 shares acquired under the Issuer's Employee Stock Purchase Plan on February 28, 2022.
F3 The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on January 17, 2020.